Geneos Wealth Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $618K | Sell |
36,896
-32,938
| -47% | -$552K | 0.02% | 648 |
|
|
2025
Q1 | $1.07M | Buy |
69,834
+46,712
| +202% | +$718K | 0.02% | 641 |
|
|
2024
Q4 | $510K | Sell |
23,122
-19,400
| -46% | -$428K | 0.02% | 582 |
|
|
2024
Q3 | $766K | Sell |
42,522
-4,560
| -10% | -$82.2K | 0.03% | 459 |
|
|
2024
Q2 | $765K | Buy |
47,082
+100
| +0.2% | +$1.63K | 0.03% | 404 |
|
|
2024
Q1 | $663K | Sell |
46,982
-114
| -0.2% | -$1.61K | 0.03% | 429 |
|
|
2023
Q4 | $492K | Sell |
47,096
-3,000
| -6% | -$31.3K | 0.02% | 487 |
|
|
2023
Q3 | $511K | Sell |
50,096
-1,186
| -2% | -$12.1K | 0.03% | 458 |
|
|
2023
Q2 | $386K | Buy |
51,282
+200
| +0.4% | +$1.51K | 0.02% | 514 |
|
|
2023
Q1 | $452K | Sell |
51,082
-475
| -0.9% | -$4.2K | 0.03% | 464 |
|
|
2022
Q4 | $470K | Sell |
51,557
-3,100
| -6% | -$28.3K | 0.03% | 437 |
|
|
2022
Q3 | $441K | Sell |
54,657
-11,125
| -17% | -$89.8K | 0.03% | 420 |
|
|
2022
Q2 | $519K | Sell |
65,782
-6,200
| -9% | -$48.9K | 0.03% | 484 |
|
|
2022
Q1 | $675K | Buy |
71,982
+11,044
| +18% | +$104K | 0.03% | 465 |
|
|
2021
Q4 | $488K | Buy |
60,938
+6,133
| +11% | +$49.1K | 0.02% | 583 |
|
|
2021
Q3 | $531K | Sell |
54,805
-800
| -1% | -$7.75K | 0.02% | 546 |
|
|
2021
Q2 | $546K | Sell |
55,605
-5,381
| -9% | -$52.8K | 0.02% | 545 |
|
|
2021
Q1 | $652K | Sell |
60,986
-571
| -0.9% | -$6.11K | 0.02% | 564 |
|
|
2020
Q4 | $639K | Buy |
61,557
+14,650
| +31% | +$152K | 0.03% | 470 |
|
|
2020
Q3 | $409K | Sell |
46,907
-8,665
| -16% | -$75.6K | 0.02% | 483 |
|
|
2020
Q2 | $677K | Buy |
55,572
+9,550
| +21% | +$116K | 0.04% | 355 |
|
|
2020
Q1 | $347K | Buy |
46,022
+8,928
| +24% | +$67.3K | 0.02% | 454 |
|
|
2019
Q4 | $369K | Buy |
37,094
+2,550
| +7% | +$25.4K | 0.02% | 509 |
|
|
2019
Q3 | $239K | Sell |
34,544
-307
| -0.9% | -$2.12K | 0.01% | 591 |
|
|
2019
Q2 | $321K | Buy |
34,851
+1,320
| +4% | +$12.2K | 0.02% | 525 |
|
|
2019
Q1 | $525K | Buy |
33,531
+705
| +2% | +$11K | 0.03% | 386 |
|
|
2018
Q4 | $515K | Sell |
32,826
-1,950
| -6% | -$30.6K | 0.04% | 365 |
|
|
2018
Q3 | $749K | Buy |
34,776
+22,882
| +192% | +$493K | 0.05% | 311 |
|
|
2018
Q2 | $289K | Sell |
11,894
-9,957
| -46% | -$242K | 0.02% | 455 |
|
|
2018
Q1 | $373K | Sell |
21,851
-17,232
| -44% | -$294K | 0.03% | 367 |
|
|
2017
Q4 | $740K | Sell |
39,083
-1,075
| -3% | -$20.4K | 0.07% | 256 |
|
|
2017
Q3 | $706K | Sell |
40,158
-1,097
| -3% | -$19.3K | 0.07% | 244 |
|
|
2017
Q2 | $1.37M | Buy |
41,255
+11,885
| +40% | +$395K | 0.14% | 149 |
|
|
2017
Q1 | $942K | Buy |
29,370
+3,434
| +13% | +$110K | 0.1% | 182 |
|
|
2016
Q4 | $940K | Buy |
25,936
+19,085
| +279% | +$692K | 0.12% | 167 |
|
|
2016
Q3 | $315K | Buy |
6,851
+333
| +5% | +$15.3K | 0.04% | 346 |
|
|
2016
Q2 | $326K | Sell |
6,518
-317
| -5% | -$15.9K | 0.05% | 326 |
|
|
2016
Q1 | $370K | Buy |
+6,835
| New | +$370K | 0.06% | 294 |
|